J Malý
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 10
-
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Chemotherapy-induced cardiotoxicity and mitigation 9
- Hematology top 5%
- Multiple Myeloma Research and Treatments 8
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 12
-
- Lipoproteins and Cardiovascular Health 11
-
- Cancer Treatment and Pharmacology 11
-
- Lymphoma Diagnosis and Treatment 7
- Journals
- Physiological Research (10 papers)Atherosclerosis Supplements (5 papers)European Journal of Endocrinology (2 papers)
- Partner nations
- CzechiaUnited StatesUnited Kingdom
In The Last Decade
J Malý
115 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Internal Medicine 77
- Cardiology and Cardiovascular Medicine 423
- Hematology 161
- Endocrinology, Diabetes and Metabolism 236
- Genetics 132
Countries citing papers authored by J Malý
This map shows the geographic impact of J Malý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Malý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Malý more than expected).
Fields of papers citing papers by J Malý
This network shows the impact of papers produced by J Malý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Malý. The network helps show where J Malý may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Malý, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 6 | |
| 2 | 2013 | 8 | |
| 3 | 2012 | 3 | |
| 4 | Thyroid hormone abnormalities in haemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality | 2012 | 2 |
| 5 | 2012 | 30 | |
| 6 | 2011 | 4 | |
| 7 | 2010 | 4 | |
| 8 | 2010 | 13 | |
| 9 | 2010 | 19 | |
| 10 | 2009 | 17 | |
| 11 | 2009 | 7 | |
| 12 | 2009 | 9 | |
| 13 | 2006 | 10 | |
| 14 | 2006 | 5 | |
| 15 | 2005 | 6 | |
| 16 | 2004 | 9 | |
| 17 | 2003 | 2 | |
| 18 | 2002 | 6 | |
| 19 | 1995 | 0 | |
| 20 | 1995 | 7 |
About J Malý
J Malý is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 124 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Lipoproteins and Cardiovascular Health (11 papers), Cancer Treatment and Pharmacology (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Internal Medicine (77 citations), Cardiology and Cardiovascular Medicine (423 citations) and Hematology (161 citations). J Malý has collaborated with scholars based in Czechia, United States and United Kingdom. Frequent co-authors include Ladislav Jebavý, Jan M. Horáček, Radek Pudil, M. Tichý, M. Bláha, V. Bláha, Lukáš Smolej, J Horáček, M Pecka and Nancy U. Lin. Their work appears in journals such as Physiological Research, Atherosclerosis Supplements, European Journal of Endocrinology, European Journal Of Haematology and Acta Ophthalmologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.